Tianish Laboratories Private Limited – FDA 483, Sep 13, 2022
An FDA inspection of Mylan Laboratories Limited – Unit 7, an API manufacturer in Patancheru, India, revealed significant deficiencies, including a repeat observation for failure to validate analytical test methods for APIs and intermediates. The firm also failed to adequately clean and maintain equipment, had an inadequate procedure for investigating critical quality events, and conducted a flawed cleaning validation study. These issues indicate a lack of control over manufacturing processes and quality systems.
ID · 7f45d719-db20-49a5-a320-27591070c678
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.